What we achieved
Commercialization of results from basic research since 2010
- on average 10 awarded patents per year
- 11 signed license agreements
- 8 incubated projects in the area of treatment of cancer, CNS diseases, inflammation, infection and liver diseases; project iBodies
Selected partners
- Merck Millipore – labeled nucleoside triphosphates transporting system for labeling DNA of living cells (already available on market as BioTracker™ NTP-Transporter Molecule)
- Novo Nordisk – novel ways for the treatment of obesity and related diseases
- Shine – a novel technology for 177-Lu isolation